S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

MMSI Merit Medical Systems Inc

96.72

0.22 (0.23%)

Dec 31 2024 - Closed

Delayed by 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

11/05/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Raul Parra, Jr.

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Merit Medical Systems (NASDAQ:MMSI)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Merit Medical Systems Charts.

Merit Medical Systems (NASDAQ:MMSI)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Merit Medical Systems Charts.

Merit Medical Systems Inc News

Merit Medical Announces FDA Approval of the WRAPSODY Cell-Impermeable Endoprosthesis
Friday 20 December 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 19 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Merit Medical Announces Resignation of President, Joseph Wright
Monday 16 December 2024 (2 weeks ago) • GlobeNewswire Inc.

Merit Medical’s WRAPSODY WAVE Trial Exceeds Performance Goals for Arteriovenous Graft (AVG) Patients
Monday 25 November 2024 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Monday 18 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 5 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 5 November 2024 (2 months ago) • Edgar (US Regulatory)

More Merit Medical Systems Inc News Articles

Anavex Life Sciences

Decentral Life (PK)

Accredited Solutions (PK)

Digital Brand Media and ... (PK)

Kraig Biocraft Laborator... (QB)

Fannie Mae (QB)

Lightwave Logic

Code Green Apparel (PK)

North Bay Resources (PK)

Intergrated Cannabis Sol... (PK)

Elite Pharmaceuticals (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions